We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Earlier Surgery May Reduce Anesthesia Problems

By HospiMedica staff writers
Posted on 21 Aug 2006
Scheduling surgery earlier in the day may help prevent unexpected problems related to anesthesia, including added pain and postoperative nausea and vomiting, according to a new study. More...


Researchers at the Duke University Medical Center (Durham, NC, USA) analyzed more than 90,000 surgeries performed at the hospital between the years 2000-2004. The researchers analyzed a database maintained by the hospital that contains a record of each surgical patient's course of treatment from hospital admission to discharge, and found that patients whose surgeries began around 4 p.m. were about four times more likely to request pain medication than those whose surgeries started around 9 a.m. Looking for the cause of this finding, they divided the problems encountered into three categories: error, harm, and other adverse events.

The 31 incidents placed in the error category included improper dosing of patients with anesthetic agents. The researchers deemed 667 incidents as "harmful,” ranging from prolonged sedation to an infected wound, with postoperative nausea and vomiting accounting for 35% of these incidents. There were 1,995 other incidents,” which included potentially dangerous changes in blood pressure and problems with operating room equipment. The study identified several possible reasons why there were more problems later in the day, including tired health care workers and swings in people's natural ups and downs during the day. Doctors arriving late for surgery, a lack of transporters available to move patients, and delays in completing test results were also possible sources of late-day problems. The study was published in the August 2006 issue of the journal Quality & Safety in Health Care.

"On the positive side we didn't find anything that showed people were being hurt badly by this,” said lead author Dr. Melanie Wright, a human factors specialist at Duke University. "But it points to something we can look at more closely: can we improve quality care?”



Related Links:
Duke University Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.